Breakdown | |||||
TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
382.72M | 405.36B | 448.18M | 512.40M | 549.18M | 364.18M | Gross Profit |
332.82M | 354.69B | 391.38M | 449.71M | 309.93M | 209.57M | EBIT |
84.21M | 88.99B | 51.80M | 87.28M | -967.59M | -538.69M | EBITDA |
90.88M | 104.40B | 58.21M | 89.86M | -964.92M | -535.96M | Net Income Common Stockholders |
43.27M | 93.11B | 1.78M | 101.17M | -953.88M | -537.90M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
79.18M | 97.88M | 155.17M | 158.57M | 139.08M | 114.42M | Total Assets |
239.56M | 259.51M | 396.56M | 442.51M | 421.55M | 284.81M | Total Debt |
1.76M | 4.37M | 5.81M | 7.32M | 8.21M | 8.90M | Net Debt |
-77.42M | -93.51M | -149.36M | -151.26M | -130.87M | -105.52M | Total Liabilities |
457.29M | 477.44M | 685.50M | 740.89M | 826.82M | 1.21B | Stockholders Equity |
-217.73M | -12.54M | -11.08M | -21.20M | -48.55M | -914.75M |
Cash Flow | Free Cash Flow | ||||
-44.23M | -22.83M | 60.70M | 48.20M | 62.46M | 55.39M | Operating Cash Flow |
-43.58M | -22.15M | 62.43M | 48.37M | 63.63M | 55.88M | Investing Cash Flow |
12.02M | -681.00K | -1.90M | -13.24M | -8.31M | -9.65M | Financing Cash Flow |
-49.47M | -34.46M | -63.95M | -16.19M | -30.68M | -103.37M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
66 Neutral | $298.12M | 1.66 | -10.56% | 4.39% | -11.07% | 953.01% | |
63 Neutral | $240.68M | ― | -9.90% | ― | -6.52% | -2.19% | |
62 Neutral | $11.92B | 10.48 | -7.50% | 2.95% | 7.40% | -8.18% | |
59 Neutral | $259.65M | ― | -33.75% | ― | 3.84% | -76.01% | |
56 Neutral | $256.58M | 3.04 | 35.11% | 2.35% | 3828.94% | 129.01% | |
56 Neutral | $233.61M | ― | -24.47% | ― | -8.39% | 7.79% | |
51 Neutral | $243.41M | ― | -24.28% | ― | -2.23% | 19.48% |
On May 27, 2025, MarketWise announced the appointment of Dr. David Eifrig as the permanent Chief Executive Officer, following his tenure as interim CEO since August 2024. During his interim period, Dr. Eifrig achieved improved financial performance and earned the confidence of the Board, employees, and shareholders. His leadership is expected to continue driving the company’s momentum and exploring new opportunities, with a focus on delivering value to customers, partners, and shareholders.
The most recent analyst rating on (MKTW) stock is a Buy with a $2.00 price target. To see the full list of analyst forecasts on MarketWise stock, see the MKTW Stock Forecast page.
On March 31, 2025, MarketWise announced a 1-for-20 reverse stock split to address non-compliance with Nasdaq’s minimum bid price requirement. The reverse split, effective April 2, 2025, aims to increase the stock price to attract institutional investors and maintain Nasdaq listing. The company has already received shareholder approval and plans to adjust equity awards and authorized shares accordingly. The reverse split is expected to improve market perception and align the stock price with MarketWise’s market capitalization.